Selank: Anxiolytic Heptapeptide Research — GABA, Memory, and Stress Response

Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) developed at the Institute of Molecular Genetics of the Russian Academy of Sciences as a modified analogue of the endogenous immunomodulatory tetrapeptide tuftsin. Its development aimed to combine the immune-modulating properties of tuftsin with additional anxiolytic and cognitive-enhancing effects. Selank has been approved in Russia as a medicine for anxiety and asthenic disorders and has been the subject of numerous preclinical and clinical research investigations exploring its effects on the GABAergic system, neurotrophic factor regulation, and stress-mediated cognitive impairment.

Origins: From Tuftsin to Selank

Tuftsin is a naturally occurring tetrapeptide (Thr-Lys-Pro-Arg) derived from the Fc region of IgG immunoglobulins. It is primarily known as an immune stimulator with activity on macrophages and natural killer cells. Selank extends the tuftsin sequence with three additional amino acids (Pro-Gly-Pro) that appear to stabilise the peptide against rapid enzymatic degradation and are believed to contribute to its anxiolytic and nootropic properties. This structural addition dramatically extends Selank's research-relevant biological half-life compared to tuftsin itself.

Mechanisms of Anxiolytic Action

GABAergic Modulation

Research has identified enhancement of GABAergic neurotransmission as a primary mechanism underlying Selank's anxiolytic properties. The GABAergic system — mediated by gamma-aminobutyric acid, the principal inhibitory neurotransmitter — plays a central role in anxiety regulation, and compounds that potentiate GABA-A receptor activity are among the most effective anxiolytics known. Research in rodent models has found that Selank modulates GABA-A receptor expression and sensitivity, producing anxiolytic effects without the sedation, tolerance, or dependence associated with benzodiazepine-class GABAergic compounds.

Serotonin and Dopamine System Interaction

Studies have also reported Selank's interactions with monoamine neurotransmitter systems. Research in rodent anxiety models suggests that Selank modulates the turnover of serotonin and dopamine in stress-relevant brain regions including the amygdala, hippocampus, and frontal cortex. These effects may contribute both to anxiolytic action and to the cognitive improvements observed in research subjects, as both serotonin and dopamine play critical roles in working memory, attention, and emotional regulation.

Cognitive Research Applications

BDNF Upregulation

Brain-derived neurotrophic factor (BDNF) is a neurotrophin critical for synaptic plasticity, learning, and memory consolidation. Research has found that Selank administration increases BDNF mRNA expression and protein levels in rodent brain regions involved in learning and memory, particularly the hippocampus. This neurotrophic activity represents a potential mechanism by which Selank may enhance cognitive performance and protect against stress-induced memory impairment in research models.

Memory and Learning in Stress Models

Preclinical research using rodent models of chronic mild stress and learned helplessness has investigated Selank's effects on memory and learning performance. Key findings include:

• Improved performance in spatial memory tasks (Morris water maze) in chronically stressed research subjects
• Attenuated stress-induced deficits in contextual fear memory consolidation
• Reduced anhedonia and motivational deficits in stress-exposed animal cohorts
• Normalisation of hippocampal BDNF levels that are typically reduced by chronic stress protocols

Immune System Research

Consistent with its tuftsin-derived origins, Selank retains immunomodulatory properties that have been investigated independently of its neurological effects. Research has found that Selank influences cytokine production — particularly modulating the balance of IL-6, IFN-gamma, and IL-10 — and may enhance natural killer cell activity. The combination of anxiolytic and immunomodulatory properties in a single peptide makes Selank a compound of interest to researchers investigating the well-documented bidirectional relationship between chronic stress, anxiety, and immune function.

Conclusion

Selank represents a distinctive class of research compound: a structurally modified tuftsin analogue that has evolved into a multi-target neurological and immunological research tool. Its GABAergic anxiolytic mechanisms, BDNF-mediated nootropic properties, and stress-attenuating effects in preclinical models collectively establish it as one of the most scientifically grounded Russian-developed neuropeptides. For researchers studying anxiety biology, cognitive neuroscience, or the stress–immune axis, Selank offers a unique investigational profile. For a complementary neuropeptide with a focus on neuroprotection, see our Semax neuroprotective research article. Researchers in Malaysia can also review the regulatory context in our guide on whether peptides are legal in Malaysia.